JP2002535401A5 - - Google Patents

Download PDF

Info

Publication number
JP2002535401A5
JP2002535401A5 JP2000596000A JP2000596000A JP2002535401A5 JP 2002535401 A5 JP2002535401 A5 JP 2002535401A5 JP 2000596000 A JP2000596000 A JP 2000596000A JP 2000596000 A JP2000596000 A JP 2000596000A JP 2002535401 A5 JP2002535401 A5 JP 2002535401A5
Authority
JP
Japan
Prior art keywords
strong
weak
medium
omeprazole
potassium salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000596000A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002535401A (ja
Filing date
Publication date
Priority claimed from SE9900274A external-priority patent/SE9900274D0/xx
Application filed filed Critical
Publication of JP2002535401A publication Critical patent/JP2002535401A/ja
Publication of JP2002535401A5 publication Critical patent/JP2002535401A5/ja
Pending legal-status Critical Current

Links

JP2000596000A 1999-01-28 2000-01-18 （ｓ）−オメプラゾールのカリウム塩 Pending JP2002535401A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9900274A SE9900274D0 (sv) 1999-01-28 1999-01-28 New compound
SE9900274-3 1999-01-28
PCT/SE2000/000087 WO2000044744A1 (en) 1999-01-28 2000-01-18 Potassium salt of ($i(s))-omeprazole

Publications (2)

Publication Number Publication Date
JP2002535401A JP2002535401A (ja) 2002-10-22
JP2002535401A5 true JP2002535401A5 (enExample) 2007-01-25

Family

ID=20414267

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000596000A Pending JP2002535401A (ja) 1999-01-28 2000-01-18 （ｓ）−オメプラゾールのカリウム塩

Country Status (40)

Country Link
US (1) US6511996B1 (enExample)
EP (1) EP1149090B1 (enExample)
JP (1) JP2002535401A (enExample)
KR (1) KR100624054B1 (enExample)
CN (1) CN1231477C (enExample)
AR (1) AR022425A1 (enExample)
AT (1) ATE236899T1 (enExample)
AU (1) AU768676B2 (enExample)
BG (1) BG65060B1 (enExample)
BR (1) BR0007647A (enExample)
CA (1) CA2357744C (enExample)
CZ (1) CZ300504B6 (enExample)
DE (1) DE60002042T2 (enExample)
DK (1) DK1149090T3 (enExample)
DZ (1) DZ3001A1 (enExample)
EE (1) EE04240B1 (enExample)
EG (1) EG23980A (enExample)
ES (1) ES2193937T3 (enExample)
HK (1) HK1041259B (enExample)
HU (1) HU226766B1 (enExample)
ID (1) ID30095A (enExample)
IL (1) IL144107A0 (enExample)
IS (1) IS2019B (enExample)
MY (1) MY119095A (enExample)
NO (1) NO319719B1 (enExample)
NZ (1) NZ512804A (enExample)
PL (1) PL197881B1 (enExample)
PT (1) PT1149090E (enExample)
RS (1) RS50200B (enExample)
RU (1) RU2237666C2 (enExample)
SA (1) SA00200895B1 (enExample)
SE (1) SE9900274D0 (enExample)
SI (1) SI1149090T1 (enExample)
SK (1) SK285626B6 (enExample)
TN (1) TNSN00017A1 (enExample)
TR (1) TR200102138T2 (enExample)
TW (1) TWI269795B (enExample)
UA (1) UA71594C2 (enExample)
WO (1) WO2000044744A1 (enExample)
ZA (1) ZA200105526B (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6875872B1 (en) * 1993-05-28 2005-04-05 Astrazeneca Compounds
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
EP1633736A1 (en) * 2003-05-05 2006-03-15 Ranbaxy Laboratories Limited Barium salt of benzimidazole derivative
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
JP2007532677A (ja) * 2004-04-16 2007-11-15 サンタラス インコーポレイティッド プロトンポンプ阻害剤、緩衝剤、および運動促進薬の組み合わせ
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2006001753A1 (en) * 2004-06-24 2006-01-05 Astrazeneca Ab New process for the preparation of crystal modifications for use in the preparation of esomeprazole sodium salt
US20060160783A1 (en) * 2004-12-30 2006-07-20 Transform Pharmaceuticals, Inc. Novel omeprazole forms and related methods
ES2259269B1 (es) 2005-03-03 2007-11-01 Esteve Quimica, S.A. Procedimiento para la preparacion de derivados de 2-(2-piridilmetilsulfinil)-bencimidazol opticamente activos.
US7576219B2 (en) 2005-10-26 2009-08-18 Hanmi Pharm. Co., Ltd Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
CA2626085C (en) * 2005-10-26 2011-12-06 Hanmi Pharm. Co., Ltd. S-omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same
EP1801110A1 (en) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Esomeprazole arginine salt
CN100384839C (zh) * 2006-02-17 2008-04-30 中国科学院上海有机化学研究所 [(取代的吡啶基)甲基]亚磺酰基-1h-苯并咪唑类化合物及其对映体的锌盐的制备方法
US20100286208A1 (en) * 2006-06-21 2010-11-11 Bobba Venkata Siva Kumar Novel polymorph of esomeprazole potassium and process for its preparation
CA2665226C (en) 2006-10-05 2014-05-13 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
MX2009004475A (es) 2006-10-27 2009-08-12 Univ Missouri Composiciones que comprenden agentes acido labiles que inhiben la bomba de protones, por lo menos otro agente farmaceuticamente activo y metodos de uso de las misma.
US7906678B2 (en) 2006-12-04 2011-03-15 Bayer Schering Pharma Aktiengesellschaft Crystalline potassium salt of lipoxin A4 analogs
FR2920428B1 (fr) * 2007-08-29 2012-06-15 Univ Rouen Procede de dedoublement de sels de l'omeprazole
WO2009074997A2 (en) * 2007-12-10 2009-06-18 Lee Pharma Ltd. A novel process for the preparation of crystalline magnesium salt of (s)-omeprazole di hydrate
EP2143722A1 (en) 2008-07-09 2010-01-13 Lek Pharmaceuticals D.D. Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium
WO2010097583A1 (en) 2009-02-24 2010-09-02 Cipla Limited Esomeprazole potassium polymorph and its preparation
WO2010122583A2 (en) 2009-04-24 2010-10-28 Rubicon Research Private Limited Oral pharmaceutical compositions of acid labile substances
EP2510089B1 (en) 2009-12-08 2015-10-21 Codexis, Inc. Synthesis of prazole compounds
CN102319223B (zh) * 2011-09-21 2013-06-19 石药集团欧意药业有限公司 一种埃索美拉唑冻干制剂及其制备方法
CN102633776B (zh) * 2012-03-28 2014-06-18 中山市仁合药业有限公司 一种埃索美拉唑及其钠盐的制备方法
WO2024075017A1 (en) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition of aortic valve calcification

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE8301182D0 (sv) 1983-03-04 1983-03-04 Haessle Ab Novel compounds
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
SE8804629D0 (sv) * 1988-12-22 1988-12-22 Ab Haessle New therapeutically active compounds
DE4035455A1 (de) 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
US5877192A (en) 1993-05-28 1999-03-02 Astra Aktiebolag Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
MX9600857A (es) 1994-07-08 1997-06-28 Astra Ab Forma de dosificacion i en tabletas, con unidades multiples.
SE504459C2 (sv) 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
GB9423970D0 (en) 1994-11-28 1995-01-11 Astra Ab Oxidation
GB9423968D0 (en) 1994-11-28 1995-01-11 Astra Ab Resolution
HRP960232A2 (en) 1995-07-03 1998-02-28 Astra Ab A process for the optical purification of compounds
SE510666C2 (sv) * 1996-12-20 1999-06-14 Astra Ab Nya Kristallmodifikationer
SE510650C2 (sv) 1997-05-30 1999-06-14 Astra Ab Ny förening
SE510643C2 (sv) * 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B

Similar Documents

Publication Publication Date Title
JP2002535401A5 (enExample)
JP6938561B2 (ja) 重水素化２，４−チアゾリジンジオン及び治療方法
RU2001119054A (ru) Калиевая соль (S)-омепразола
JP5412023B2 (ja) ベンズイミダゾール化合物の塩およびその用途
JP3457945B2 (ja) オメプラゾールの新規な結晶形
CA2688695A1 (en) Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
JP2002523502A5 (enExample)
TW200800185A (en) Acid secretion inhibitor
IL166855A (en) Annals of compressed pyrimidine with azaleas that inhibit pi3k activity and drugs containing them.
JP2000516913A (ja) 細胞増殖抑制剤および免疫抑制剤としてのピリジルアルケン―およびピリジルアルキン―酸アミド類
JP2000512652A (ja) 腫瘍の治療または免疫抑制におけるピリジルアルカン、ピリジルアルケンおよび／またはピリジルアルキン酸アミド類の用途
JP2006514626A5 (enExample)
MXPA04002338A (es) Derivados de carbazol y su uso como antagonistas receptores del npy5.
HUP0105313A2 (hu) (S)-Omeprazol káliumsója, eljárás az előállítására, ezt tartalmazó gyógyszerkészítmény és alkalmazása
JP2000512651A (ja) 細胞増殖抑制剤および免疫抑制剤としての新規なピリジルアルカン酸アミド類
JP2011513202A (ja) ベンズイミダゾール化合物の結晶
HRP20030853A2 (en) Crystalline form of omeprazole
WO2002020058A1 (en) Preparations for oral administration
WO2004080439A1 (ja) 高濃度に活性成分を球形核に付着させた医薬組成物
JP2003513075A5 (enExample)
JP2002508373A5 (enExample)
JPWO2003106429A1 (ja) プロドラッグおよびその製造法
CA2474246A1 (en) Alkylammonium salts of omeprazole and esomeprazole
JP2006501313A (ja) （ｓ）−パントプラゾールの塩及びその水和物
JP2005501091A5 (enExample)